Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma

Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma

This review article outlines the current development of emerging treatment strategies for primary central nervous system lymphoma, a rare brain tumor with, thus far, limited therapeutic options. Small molecule targeted tyrosine kinase inhibitors, immunomodulatory agents, and immune checkpoint inhibi...

Full description

Bibliographic Details
Main Authors: Hans-Georg Wirsching, Michael Weller, Stefan Balabanov, Patrick Roth
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
primary CNS lymphoma
PCNSL
ibrutinib
lenalidomide
immune checkpoint inhibition
PD-1
Online Access:https://www.mdpi.com/2072-6694/13/12/3073

Similar Items

Similar Items